P3 Health Partners Inc reports results for the quarter ended September 30 - Earnings Summary

• P3 Health Partners Inc PIII.OQ reported a quarterly adjusted loss of 29 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -12 cents. The mean expectation of five analysts for the quarter was for a loss of 4 cents per share. Wall Street expected results to range from -6 cents to -3 cents per share.

• Revenue rose 25.6% to $362.12 million from a year ago; analysts expected $364.45 million.

• P3 Health Partners Inc's reported EPS for the quarter was a loss of 29 cents​.

• The company reported a quarterly loss of $46.51 million.

• P3 Health Partners Inc shares had risen by 1.1% this quarter and lost 72.3% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for P3 Health Partners Inc is 1.00

This summary was machine generated from LSEG data November 13 at 02:25 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)